Posted

57 replies · 781 reposts · 998 likes

NEW - BioNTech says in its annual report to the US Securities and Exchange Commission that the efficacy of its current mRNA Corona vaccine may not be sufficient for permanent regulatory approval. https://investors.biontech.de/node/11931/html#ic5e06a05a31d4c4491031d3208cef8c2_2806

View this post on Gab